| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $886K | +365.9% |
| R&D Expense | $6.2M | +122.9% |
| SG&A Expense | $9.1M | +16.1% |
| Operating Income | -$14.7M | -36.6% |
| Pre-tax Income | -$14.3M | +27.2% |
| Income Tax | $3K | +0.0% |
| Net Income | -$14.3M | +26.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $98K | +7.3% |
| Current Assets | $10.1M | -7.6% |
| Total Assets | $14.5M | -6.1% |
| Current Liabilities | $3.0M | +77.6% |
| Total Liabilities | $3.0M | +33.5% |
| Stockholders' Equity | $11.5M | -12.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.6M | -38.8% |
| Investing Cash Flow | -$66K | -187.5% |
| Financing Cash Flow | $10.0M | -35.1% |